United States · FDA National Drug Code directory
Besivance
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-257_57410dc3-5ac5-b323-e063-6394a90a1a0a
- Product NDC
- 85766-257
- Form
- SUSPENSION
- Composition / generic term
- Besifloxacin
- Labeler
- Sportpharm LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090528
- Source listing expiry
- 20271231
Source-listed ingredients
- BESIFLOXACIN — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (85766-257-05) / 5 mL in 1 BOTTLE, DROPPER · 85766-257-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →